Feature Channels: Stem Cells

Filters close
Released: 29-Jan-2022 12:00 PM EST
Matrix vesicles from dental follicle cells improve alveolar bone regeneration via activation of the PLC/PKC/MAPK pathway
Stem Cell Research & Therapy

The regeneration of bone loss that occurs after periodontal diseases is a significant challenge in clinical dentistry. Extracellular vesicles (EVs)-based cell-free regenerative therapies represent a promising ...

Released: 29-Jan-2022 12:00 PM EST
Dental-derived mesenchymal stem cell sheets: a prospective tissue engineering for regenerative medicine
Stem Cell Research & Therapy

Stem cells transplantation is the main method of tissue engineering regeneration treatment, the viability and therapeutic efficiency are limited. Scaffold materials also play an important role in tissue engine...

Released: 29-Jan-2022 12:00 PM EST
G protein-coupled receptor kinase 3 modulates mesenchymal stem cell proliferation and differentiation through sphingosine-1-phosphate receptor regulation
Stem Cell Research & Therapy

The bone marrow niche supports hematopoietic cell development through intimate contact with multipotent stromal mesenchymal stem cells; however, the intracellular signaling, function, and regulation of such su...

Released: 29-Jan-2022 12:00 PM EST
Mesenchymal stem cells-derived therapies for subarachnoid hemorrhage in preclinical rodent models: a meta-analysis
Stem Cell Research & Therapy

Mesenchymal stem cells (MSCs) and MSCs-derived extracellular vesicles (EVs) have emerged as potential novel therapies for subarachnoid hemorrhage (SAH). However, their effects remain incompletely understood. W...

Newswise: Thomas K. Waddell Receives Bakken Scientific Achievement Award
Released: 29-Jan-2022 11:00 AM EST
Thomas K. Waddell Receives Bakken Scientific Achievement Award
The Society of Thoracic Surgeons

Internationally recognized medical researcher, surgeon, and professor Thomas K. Waddell, MD, MSc, PhD, was honored with the 2022 Earl Bakken Scientific Achievement Award from The Society of Thoracic Surgeons.

Released: 28-Jan-2022 8:55 AM EST
Peptide hormone ELABELA promotes rat bone marrow-derived mesenchymal stem cell proliferation and migration by manipulating the cell cycle through the PI3K/AKT pathway under the hypoxia and ischemia microenvironmemt
Stem Cell Research & Therapy

Mesenchymal stem cells (MSCs) are emerging as a potential candidate for stem cell transplantation to repair myocardial tissue in myocardial infarctions (MI). However, there are some pivotal limitations such as...

Released: 28-Jan-2022 8:55 AM EST
Cell-based therapy in thin endometrium and Asherman syndrome
Stem Cell Research & Therapy

Numerous treatment strategies have so far been proposed for treating refractory thin endometrium either without or with the Asherman syndrome. Inconsistency in the improvement of endometrial thickness is a com...

Released: 28-Jan-2022 8:55 AM EST
A new direction in managing avulsed teeth: stem cell-based de novo PDL regeneration
Stem Cell Research & Therapy

Management of avulsed teeth after replantation often leads to an unfavorable outcome. Damage to the thin and vulnerable periodontal ligament is the key reason for failure. Cell- or stem cell-based regenerative...

Released: 28-Jan-2022 8:55 AM EST
Prednisolone and mesenchymal stem cell preloading protect liver cell migration and mitigate extracellular matrix modification in transplanted decellularized rat liver
Stem Cell Research & Therapy

Regenerative medicine provides promising approaches for treating chronic liver diseases. Previous studies indicate that decellularized liver architecture is damaged by invading non-hepatic inflammatory cells. ...

Released: 28-Jan-2022 8:55 AM EST
First-in-human autologous oral mucosal epithelial sheet transplantation to prevent anastomotic re-stenosis in congenital esophageal atresia
Stem Cell Research & Therapy

Congenital esophageal atresia postoperative anastomotic stricture occurs in 30–50% of cases. Patients with severe dysphagia are treated with endoscopic balloon dilatation (EBD) and/or local injection of steroi...

Newswise: Scientists Regrow Frog’s Lost Leg
24-Jan-2022 9:50 AM EST
Scientists Regrow Frog’s Lost Leg
Tufts University

Scientists have triggered long-term growth of legs in adult frogs, which are naturally unable to regenerate limbs. The frogs regrew a lost leg over months, triggered by just 24 hour exposure to a five-drug cocktail held under a bioreactor. The new legs were functional enough to enable sensation and locomotion.

Released: 26-Jan-2022 12:00 PM EST
Multiple roles of mothers against decapentaplegic homolog 4 in tumorigenesis, stem cells, drug resistance, and cancer therapy
World Journal of Stem Cells

The transforming growth factor (TGF)-β signaling pathway controls many cellular processes, including proliferation, differentiation, and apoptosis. Abnormalities in the TGF-β signaling pathway and its components are closely related to the occ

Released: 26-Jan-2022 12:00 PM EST
Stem cell therapy applied for digestive anastomosis: Current state and future perspectives
World Journal of Stem Cells

BACKGROUNDDigestive tract resections are usually followed by an anastomosis. Anastomotic leakage, normally due to failed healing, is the most feared complication in digestive surgery because it is associated with high morbidity and mortality. D

Released: 26-Jan-2022 12:00 PM EST
Modified mesenchymal stem cells in cancer therapy: A smart weapon requiring upgrades for wider clinical applications
World Journal of Stem Cells

Mesenchymal stem stromal cells (MSC) are characterized by the intriguing capacity to home toward cancer cells after systemic administration. Thus, MSC can be harnessed as targeted delivery vehicles of cytotoxic agents against tumors. In cancer

Released: 26-Jan-2022 12:00 PM EST
MD Anderson Research Highlights for January 26, 2022
University of Texas MD Anderson Cancer Center

The University of Texas MD Anderson Cancer Center’s Research Highlights provides a glimpse into recently published studies in basic, translational and clinical cancer research from MD Anderson experts. Current clinical advances include combination therapies for thyroid cancer and multiple myeloma, as well as discoveries to improve CRISPR/Cas9 gene editing, to identify biomarkers for immunotherapy response, to utilize T cell therapy for osteosarcoma and to understand of the role of LIP-1 in regulating ERK signaling.

Released: 26-Jan-2022 12:00 PM EST
Insight into generation of induced mesenchymal stem cells from induced pluripotent cells
World Journal of Stem Cells

Mesenchymal stem cells (MSCs) have the potential for use in cell-based regenerative therapies. Currently, hundreds of clinical trials are using MSCs for the treatment of various diseases. However, MSCs are low in number in adult tissues; they s

Released: 26-Jan-2022 12:00 PM EST
Therapeutic effects of menstrual blood-derived endometrial stem cells on mouse models of streptozotocin-induced type 1 diabetes
World Journal of Stem Cells

BACKGROUNDType 1 diabetes (T1D), a chronic metabolic and autoimmune disease, seriously endangers human health. In recent years, mesenchymal stem cell (MSC) transplantation has become an effective treatment for diabetes. Menstrual blood-derived

Released: 26-Jan-2022 12:00 PM EST
Molecular mechanism of therapeutic approaches for human gastric cancer stem cells
World Journal of Stem Cells

Gastric cancer (GC) is a primary cause of cancer-related mortality worldwide, and even after therapeutic gastrectomy, survival rates remain poor. The presence of gastric cancer stem cells (GCSCs) is thought to be the major reason for resistance

Released: 26-Jan-2022 12:00 PM EST
Epigenetic regulation by long noncoding RNAs in osteo-/adipogenic differentiation of mesenchymal stromal cells and degenerative bone diseases
World Journal of Stem Cells

Bone is a complex tissue that undergoes constant remodeling to maintain homeostasis, which requires coordinated multilineage differentiation and proper proliferation of mesenchymal stromal cells (MSCs). Mounting evidence indicates that a distur



close
2.53601